Literature DB >> 20357106

Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.

Xueyi Li1, Antonio Valencia, Ellen Sapp, Nicholas Masso, Jonathan Alexander, Patrick Reeves, Kimberly B Kegel, Neil Aronin, Marian Difiglia.   

Abstract

Oxidative stress contributes to neurodegeneration in Huntington's disease (HD). However, the origins of oxidative stress in HD remain unclear. Studies in HD transgenic models suggest involvement of mitochondrial dysfunction, which would lead to overproduction of reactive oxygen species (ROS). Impaired mitochondria complexes occur in late stages of HD but not in presymptomatic or early-stage HD patients. Thus, other mechanisms may account for the earliest source of oxidative stress caused by endogenous mutant huntingtin. Here, we report that decreased levels of a major intracellular antioxidant glutathione coincide with accumulation of ROS in primary HD neurons prepared from embryos of HD knock-in mice (HD(140Q/140Q)), which have human huntingtin exon 1 with 140 CAG repeats inserted into the endogenous mouse huntingtin gene. Uptake of extracellular cysteine through the glutamate/cysteine transporter EAAC1 is required for de novo synthesis of glutathione in neurons. We found that, compared with wild-type neurons, HD neurons had lower cell surface levels of EAAC1 and were deficient in taking up cysteine. Constitutive trafficking of EAAC1 from recycling endosomes relies on Rab11 activity, which is defective in the brain of HD(140Q/140Q) mice. Enhancement of Rab11 activity by expression of a dominant-active Rab11 mutant in primary HD neurons ameliorated the deficit in cysteine uptake, increased levels of intracellular glutathione, normalized clearance of ROS, and improved neuronal survival. Our data support a novel mechanism for oxidative stress in HD: Rab11 dysfunction slows trafficking of EAAC1 to the cell surface and impairs cysteine uptake, thereby leading to deficient synthesis of glutathione.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357106      PMCID: PMC3842456          DOI: 10.1523/JNEUROSCI.5865-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus.

Authors:  Y He; W G Janssen; J D Rothstein; J H Morrison
Journal:  J Comp Neurol       Date:  2000-03-13       Impact factor: 3.215

2.  Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice.

Authors:  Jorge M A Oliveira; Mika B Jekabsons; Sylvia Chen; Amy Lin; A Cristina Rego; Jorge Gonçalves; Lisa M Ellerby; David G Nicholls
Journal:  J Neurochem       Date:  2007-04       Impact factor: 5.372

3.  Plasma membrane expression of the neuronal glutamate transporter EAAC1 is regulated by glial factors: evidence for different regulatory pathways associated with neuronal maturation.

Authors:  S Lortet; B Canolle; F Masmejean; A Nieoullon
Journal:  Neurochem Int       Date:  2008-03-02       Impact factor: 3.921

4.  Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.

Authors:  Heather L Wieman; Jessica A Wofford; Jeffrey C Rathmell
Journal:  Mol Biol Cell       Date:  2007-02-14       Impact factor: 4.138

5.  Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2007-03-13       Impact factor: 6.150

6.  Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Authors:  N Klepac; M Relja; R Klepac; S Hećimović; T Babić; V Trkulja
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

7.  Hyperoxia causes maturation-dependent cell death in the developing white matter.

Authors:  Bettina Gerstner; Tara M DeSilva; Kerstin Genz; Amy Armstrong; Felix Brehmer; Rachael L Neve; Ursula Felderhoff-Mueser; Joseph J Volpe; Paul A Rosenberg
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

8.  Modulation of the neural glutamate transporter EAAC1 by the addicsin-interacting protein ARL6IP1.

Authors:  Saori Akiduki; Mitsushi J Ikemoto
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

9.  Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution.

Authors:  Rebecca A Kirkland; Geraldine M Saavedra; James L Franklin
Journal:  J Neurosci       Date:  2007-10-17       Impact factor: 6.167

10.  Constitutive endocytosis and recycling of the neuronal glutamate transporter, excitatory amino acid carrier 1.

Authors:  Marco I González; Bala T S Susarla; Keith M Fournier; Amanda L Sheldon; Michael B Robinson
Journal:  J Neurochem       Date:  2007-09-14       Impact factor: 5.372

View more
  79 in total

1.  Multiple phenotypes in Huntington disease mouse neural stem cells.

Authors:  James J Ritch; Antonio Valencia; Jonathan Alexander; Ellen Sapp; Leah Gatune; Gavin R Sangrey; Saurabh Sinha; Cally M Scherber; Scott Zeitlin; Ghazaleh Sadri-Vakili; Daniel Irimia; Marian Difiglia; Kimberly B Kegel
Journal:  Mol Cell Neurosci       Date:  2012-04-06       Impact factor: 4.314

2.  Nanoparticle-mediated signaling endosome localization regulates growth cone motility and neurite growth.

Authors:  Michael B Steketee; Stavros N Moysidis; Xiao-Lu Jin; Jessica E Weinstein; Wolfgang Pita-Thomas; Hemalatha B Raju; Siraj Iqbal; Jeffrey L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 3.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

4.  Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-19       Impact factor: 11.205

Review 5.  Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.

Authors:  Anuradha Kalani; Alka Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

Review 6.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

7.  Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.

Authors:  Ana María Estrada-Sánchez; George V Rebec
Journal:  Basal Ganglia       Date:  2012-07-01

8.  Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.

Authors:  Jiu-Qiang Wang; Qian Chen; Xianhua Wang; Qiao-Chu Wang; Yun Wang; He-Ping Cheng; Caixia Guo; Qinmiao Sun; Quan Chen; Tie-Shan Tang
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

9.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Patrick B Reeves; Jonathan Alexander; Kwadwo A Ansong; Nicholas Masso; Matthew P Frosch; Kimberly B Kegel; Xueyi Li; Marian DiFiglia
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

10.  Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.

Authors:  Geraldine T Petr; Laurel A Schultheis; Kayla C Hussey; Yan Sun; Janet M Dubinsky; Chiye Aoki; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2013-04-16       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.